Cargando…

Adaptations to chronic rapamycin in mice

Rapamycin inhibits mechanistic (or mammalian) target of rapamycin (mTOR) that promotes protein production in cells by facilitating ribosome biogenesis (RiBi) and eIF4E-mediated 5'cap mRNA translation. Chronic treatment with encapsulated rapamycin (eRapa) extended health and life span for wild-t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dodds, Sherry G., Livi, Carolina B., Parihar, Manish, Hsu, Hang-Kai, Benavides, Adriana D., Morris, Jay, Javors, Martin, Strong, Randy, Christy, Barbara, Hasty, Paul, Sharp, Zelton Dave
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Co-Action Publishing 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884683/ https://www.ncbi.nlm.nih.gov/pubmed/27237224 http://dx.doi.org/10.3402/pba.v6.31688

Ejemplares similares

Rapamycin extends life span of Rb1(+/−) mice by inhibiting neuroendocrine tumors
por: Livi, Carolina B., et al.
Publicado: (2013)

Acarbose improved survival for Apc(+/Min) mice
por: Dodds, Sherry G., et al.
Publicado: (2020)

p53 and rapamycin are additive
por: Christy, Barbara, et al.
Publicado: (2015)

Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
por: Harrison, David E., et al.
Publicado: (2009)

Divergent tissue and sex effects of rapamycin on the proteasome-chaperone network of old mice
por: Rodriguez, Karl A., et al.
Publicado: (2014)

Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction
por: Miller, Richard A, et al.
Publicado: (2014)

Metabolic consequences of long-term rapamycin exposure on common marmoset monkeys (Callithrix jacchus)
por: Ross, Corinna, et al.
Publicado: (2015)

Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune‐deficient mice
por: Hurez, Vincent, et al.
Publicado: (2015)

Rapamycin-induced hyperglycemia is associated with exacerbated age-related osteoarthritis
por: Minton, Dennis M., et al.
Publicado: (2021)

Correction to: Rapamycin-induced hyperglycemia is associated with exacerbated age-related osteoarthritis
por: Minton, Dennis M., et al.
Publicado: (2022)

Rapamycin‐mediated mouse lifespan extension: Late‐life dosage regimes with sex‐specific effects
por: Strong, Randy, et al.
Publicado: (2020)

Inducing Autophagy by Rapamycin Before, but Not After, the Formation of Plaques and Tangles Ameliorates Cognitive Deficits
por: Majumder, Smita, et al.
Publicado: (2011)

Metformin reduces glucose intolerance caused by rapamycin treatment in genetically heterogeneous female mice
por: Weiss, Roxanne, et al.
Publicado: (2018)

Low-dose rapamycin extends lifespan in a mouse model of mtDNA depletion syndrome
por: Siegmund, Stephanie E, et al.
Publicado: (2017)

Rapamycin-induced metabolic defects are reversible in both lean and obese mice
por: Liu, Yuhong, et al.
Publicado: (2014)

RECQL5 and BLM exhibit divergent functions in cells defective for the Fanconi anemia pathway
por: Kim, Tae Moon, et al.
Publicado: (2015)

Lifespan benefits for the combination of rapamycin plus acarbose and for captopril in genetically heterogeneous mice
por: Strong, Randy, et al.
Publicado: (2022)

Activation of Estrogen Receptor-α by E2 or EGF Induces Temporally Distinct Patterns of Large-Scale Chromatin Modification and mRNA Transcription
por: Berno, Valeria, et al.
Publicado: (2008)

Mice Fed Rapamycin Have an Increase in Lifespan Associated with Major Changes in the Liver Transcriptome
por: Fok, Wilson C., et al.
Publicado: (2014)

Combined treatment of rapamycin and dietary restriction has a larger effect on the transcriptome and metabolome of liver
por: Fok, Wilson C, et al.
Publicado: (2014)

Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease
por: Spilman, Patricia, et al.
Publicado: (2010)

Correction: Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease
por: Spilman, Patricia, et al.
Publicado: (2011)

Correction: Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease
por: Spilman, Patricia, et al.
Publicado: (2011)

Surviving rapamycin
por: Van Epps, Heather L.
Publicado: (2005)

Rapamycin in mice
por: Swindell, William R.
Publicado: (2017)

p53 as an intervention target for cancer and aging
por: Hasty, Paul, et al.
Publicado: (2013)

Rapamycin improves motor function, reduces 4-hydroxynonenal adducted protein in brain, and attenuates synaptic injury in a mouse model of synucleinopathy
por: Bai, Xiang, et al.
Publicado: (2015)

The pivotal role of mammalian target of rapamycin inhibition in the treatment of patients with neuroendocrine tumors
por: Phan, Alexandria T., et al.
Publicado: (2016)

Impaired aldehyde detoxification exacerbates motor deficits in an alpha‐synuclein mouse model of Parkinson's disease
por: Martinez, Paul Anthony, et al.
Publicado: (2023)

Longevity, aging and rapamycin
por: Ehninger, Dan, et al.
Publicado: (2014)

Multifaceted aging and rapamycin
por: Anisimov, Vladimir N.
Publicado: (2013)

Unleashing rapamycin in fibrosis
por: Hillel, Alexander T., et al.
Publicado: (2015)

Rapamycin for the aging skin
por: Blagosklonny, Mikhail V.
Publicado: (2019)

Cancer prevention with rapamycin
por: Blagosklonny, Mikhail V.
Publicado: (2023)

Rapamycin enhances BCG-specific γδ T cells during intravesical BCG therapy for non-muscle invasive bladder cancer: a randomized, double-blind study
por: Ji, Niannian, et al.
Publicado: (2021)

Rapamycin rejuvenates oral health in aging mice
por: An, Jonathan Y, et al.
Publicado: (2020)

A microfluidic approach to rescue ALS motor neuron degeneration using rapamycin
por: Chennampally, Phaneendra, et al.
Publicado: (2021)

17ß-Estradiol Regulates mTORC2 Sensitivity to Rapamycin in Adaptive Cardiac Remodeling
por: Kusch, Angelika, et al.
Publicado: (2015)

Biodegradable Cable-Tie Rapamycin-eluting Stents
por: Lee, Cheng-Hung, et al.
Publicado: (2017)

Tomato FK506 Binding Protein 12KD (FKBP12) Mediates the Interaction between Rapamycin and Target of Rapamycin (TOR)
por: Xiong, Fangjie, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_uvphtuhdj8radl3da7oensccrb